Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading.

Adenocarcinoid Appendix Goblet cell adenocarcinoma Goblet cell carcinoid Pseudomyoma peritonei Signet ring cell carcinoma

Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
02 2023
Historique:
received: 26 05 2022
accepted: 02 06 2022
pubmed: 13 6 2022
medline: 7 2 2023
entrez: 12 6 2022
Statut: ppublish

Résumé

Goblet cell adenocarcinoma is a rare appendiceal tumour with amphicrine differentiation that has distinct morphologic and clinical features compared to carcinomas seen elsewhere in the gastrointestinal tract. These tumors have engendered considerable confusion in the literature regarding their classification, and they have been described under several different names including goblet cell carcinoid, adenocarcinoid, and adenocarcinoma, among others. In the recent fifth edition of the World Health Organization Classification of Digestive System Tumors, goblet cell adenocarcinoma is the preferred diagnosis because of the increasing recognition of a frequent co-existing high-grade adenocarcinoma component. This review will present the clinicopathologic, molecular, and immunohistochemical features of goblet cell adenocarcinoma and discuss the current challenges in diagnosis, grading, and clinical management.

Identifiants

pubmed: 35691370
pii: S0046-8177(22)00147-2
doi: 10.1016/j.humpath.2022.06.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-196

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Phoenix D Bell (PD)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA. Electronic address: pdbell06@gmail.com.

Reetesh K Pai (RK)

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH